These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27920555)

  • 1. Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity.
    Liang P; Huang C; Liang SX; Li YF; Huang SX; Lian ZP; Liu JM; Tang Y; Lu HJ
    Onco Targets Ther; 2016; 9():7169-7175. PubMed ID: 27920555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated with Stereotactic Body Radiotherapy.
    Song JH; Jeong BK; Choi HS; Jeong H; Lee YH; Kim HJ; Kim TH; Jung WT; Lee OJ; Jang HS; Choi BO; Kang KM
    J Cancer; 2017; 8(19):4155-4161. PubMed ID: 29187892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cohort study of hepatic toxicity after stereotactic body radiation therapy for hepatocellular carcinoma.
    Su TS; Luo R; Liang P; Cheng T; Zhou Y; Huang Y
    Radiother Oncol; 2018 Oct; 129(1):136-142. PubMed ID: 29548558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients.
    Liu X; Song Y; Liang P; Su T; Zhang H; Zhao X; Yuan Z; Wang P
    Onco Targets Ther; 2017; 10():5289-5295. PubMed ID: 29158680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.
    Son SH; Choi BO; Ryu MR; Kang YN; Jang JS; Bae SH; Yoon SK; Choi IB; Kang KM; Jang HS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1073-80. PubMed ID: 20207492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Velec M; Haddad CR; Craig T; Wang L; Lindsay P; Brierley J; Brade A; Ringash J; Wong R; Kim J; Dawson LA
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):939-946. PubMed ID: 28333016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.
    O'Connor JK; Trotter J; Davis GL; Dempster J; Klintmalm GB; Goldstein RM
    Liver Transpl; 2012 Aug; 18(8):949-54. PubMed ID: 22467602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) With Single Photon Emission Computed Tomography (SPECT) Functional Treatment Planning in Patients With Advanced Hepatic Cirrhosis.
    Kirichenko A; Uemura T; Liang Y; Hasan S; Abel S; Renz P; Shamsesfandabadi P; Carpenter J; Yin Y; Thai N
    Adv Radiat Oncol; 2024 Feb; 9(2):101367. PubMed ID: 38405302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach.
    Gill B; Oermann E; Ju A; Suy S; Yu X; Rabin J; Kalhorn C; Nair MN; Voyadzis JM; Unger K; Collins SP; Harter KW; Collins BT
    Front Oncol; 2012; 2():39. PubMed ID: 22645718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CyberKnife Stereotactic Body Radiation Therapy as an Effective Treatment for Hepatocellular Carcinoma Patients With Decompensated Cirrhosis.
    Sun J; Zhang A; Li W; Wang Q; Wang J; Fan Y; Sun Y; Li D; Zhang D; Duan X
    Front Oncol; 2020; 10():100. PubMed ID: 32158688
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity.
    Baumann BC; Wei J; Plastaras JP; Lukens JN; Damjanov N; Hoteit M; Hsu C; Levine M; Mondschein J; Nadolski G; Olthoff K; Reiss KA; Rosen M; Siegelman E; Metz JM; Ben-Josef E
    Am J Clin Oncol; 2018 Nov; 41(11):1118-1124. PubMed ID: 29553972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve.
    Wang PM; Chung NN; Hsu WC; Chang FL; Jang CJ; Scorsetti M
    Rep Pract Oncol Radiother; 2015; 20(6):417-24. PubMed ID: 26696781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy.
    Hasan S; Thai N; Uemura T; Kudithipudi V; Renz P; Abel S; Kirichenko AV
    World J Gastrointest Surg; 2017 Dec; 9(12):256-263. PubMed ID: 29359031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
    Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child-Pugh score classification system.
    Dyk P; Weiner A; Badiyan S; Myerson R; Parikh P; Olsen J
    Pract Radiat Oncol; 2015; 5(3):176-182. PubMed ID: 25423889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.